2,120
Views
12
CrossRef citations to date
0
Altmetric
Reviews

The current status of thermal ablation in the management of T1b renal masses

, , &
Pages 31-36 | Received 12 Feb 2019, Accepted 01 Apr 2019, Published online: 20 Sep 2019

References

  • Znaor A, Lortet-Tieulent J, Laversanne M, et al. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 2015;67:519–530.
  • Palsdottir HB, Hardarson S, Petursdottir V, et al. Incidental detection of renal cell carcinoma is an independent prognostic marker: results of a long-term, whole population study. J Urol. 2012;187:48–53.
  • Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67:913–924.
  • Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017;198:520–529.
  • Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182:1271–1279.
  • Gervais DA, McGovern FJ, Arellano RS, et al. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. Am J Roentgenol. 2005;185:64–71.
  • Zagoria RJ, Pettus JA, Rogers M, et al. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology. 2011;77:1393–1397.
  • Psutka SP, Feldman AS, McDougal WS, et al. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol. 2013;63:486–492.
  • Chang X, Zhang F, Liu T, et al. Radio frequency ablation versus partial nephrectomy for clinical T1b renal cell carcinoma: long-term clinical and oncologic outcomes. J Urol. 2015;193:430–435.
  • Iannuccilli JD, Dupuy DE, Beland MD, et al. Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients. Eur Radiol. 2016;26:1656–1664.
  • Pantelidou M, Challacombe B, McGrath A, et al. Percutaneous radiofrequency ablation versus robotic-assisted partial nephrectomy for the treatment of small renal cell carcinoma. Cardiovasc Intervent Radiol. 2016;39:1595–1603.
  • Takaki H, Soga N, Kanda H, et al. Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma. Radiology. 2014;270:292–299.
  • Atwell TD, Carter RE, Schmit GD, et al. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol. 2012;23:48–54.
  • Castle SM, Salas N, Leveillee RJ. Initial experience using microwave ablation therapy for renal tumor treatment: 18-month follow-up. Urology. 2011;77:792–797.
  • Yu J, Liang P, Yu XL, et al. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results. Radiology. 2012;263:900–908.
  • Gao Y, Liang P, Yu X, et al. Microwave treatment of renal cell carcinoma adjacent to renal sinus. Eur J Radiol. 2016;85:2083–2089.
  • Wells SA, Wheeler KM, Mithqal A, et al. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment. Abdom Radiol. 2016;41:1203–1211.
  • Chan P, Velasco S, Vesselle G, et al. Percutaneous microwave ablation of renal cancers under CT guidance: safety and efficacy with a 2-year follow-up. Clin Radiol. 2017;72:786–792.
  • Ierardi AM, Puliti A, Angileri SA, et al. Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications. Med Oncol. 2017;34:97.
  • Klapperich ME, Abel EJ, Ziemlewicz TJ, et al. Effect of tumor complexity and technique on efficacy and complications after percutaneous microwave ablation of stage T1a renal cell carcinoma: a single-center, retrospective study. Radiology. 2017;284:272–280.
  • Mansilla AV, Bivins EE, Jr., Contreras F, et al. CT-guided microwave ablation of 45 renal tumors: analysis of procedure complexity utilizing a percutaneous renal ablation complexity scoring system. J Vasc Intervent Radiol. 2017;28:222–229.
  • Thompson SM, Schmitz JJ, Thompson RH, et al. Introduction of microwave ablation into a renal ablation practice: valuable lessons learned. AJR.2018;211:1381–1389.
  • Moynagh MR, Schmit GD, Thompson RH, et al. Percutaneous cryoablation of clinical T2 (> 7 cm) renal masses: technical considerations, complications, and short-term outcomes. J Vasc Intervent Radiol. 2015;26:800–806.
  • Saliken JC, McKinnon JG, Gray R. CT for monitoring cryotherapy. AJR Am J Roentgenol. 1996;166:853–855.
  • Brashears JH, 3rd, Raj GV, Crisci A, et al. Renal cryoablation and radio frequency ablation: an evaluation of worst case scenarios in a porcine model. J Urol. 2005;173:2160–2165.
  • Janzen NK, Perry KT, Han KR, et al. The effects of intentional cryoablation and radio frequency ablation of renal tissue involving the collecting system in a porcine model. J Urol. 2005;173:1368–1374.
  • Rosenberg MD, Kim CY, Tsivian M, et al. Percutaneous cryoablation of renal lesions with radiographic ice ball involvement of the renal sinus: analysis of hemorrhagic and collecting system complications. AJR Am J Roentgenol. 2011;196:935–939.
  • Sung GT, Gill IS, Hsu TH, et al. Effect of intentional cryo-injury to the renal collecting system. J Urol. 2003;170:619–622.
  • Atwell TD, Vlaminck JJ, Boorjian SA, et al. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control. J Vasc Intervent Radiol. 2015;26:792–799.
  • Blute ML, Jr., Okhunov Z, Moreira DM, et al. Image-guided percutaneous renal cryoablation: preoperative risk factors for recurrence and complications. BJU Int. 2013;111:E181–E185.
  • Aoun HD, Littrup PJ, Jaber M, et al. Percutaneous cryoablation of renal tumors: is it time for a new paradigm shift?. J Vasc Interv Radiol. 2017;28:1363–1370.
  • Hebbadj S, Cazzato RL, Garnon J, et al. Safety considerations and local tumor control following percutaneous image-guided cryoablation of T1b renal tumors. Cardiovasc Intervent Radiol. 2018;41:449–458.
  • Caputo PA, Zargar H, Ramirez D, et al. Cryoablation versus partial nephrectomy for clinical T1b renal tumors: a matched group comparative analysis. Eur Urol. 2017;71:111–117.
  • Littrup PJ, Jallad B, Vorugu V, et al. Lethal isotherms of cryoablation in a phantom study: effects of heat load, probe size, and number. J Vasc Interv Radiol. 2009;20:1343–1351.
  • Auge BK, Santa-Cruz RW, Polascik TJ. Effect of freeze time during renal cryoablation: a swine model. J Endourol. 2006;20:1101–1105.
  • Kakarala B, Frangakis CE, Rodriguez R, et al. Hemorrhagic complications of percutaneous cryoablation for renal tumors: results from a 7-year prospective study. Cardiovasc Intervent Radiol. 2016;39:1604–1610.
  • Hruby G, Edelstein A, Karpf J, et al. Risk factors associated with renal parenchymal fracture during laparoscopic cryoablation. BJU Int. 2008;102:723–726.
  • Schmit GD, Atwell TD, Callstrom MR, et al. Ice ball fractures during percutaneous renal cryoablation: risk factors and potential implications. J Vasc Interv Radiol. 2010;21:1309–1312.
  • Woodrum DA, Atwell TD, Farrell MA, et al. Role of intraarterial embolization before cryoablation of large renal tumors: a pilot study. J Vasc Interv Radiol. 2010;21:930–936.
  • Farrell MA, Charboneau JW, Callstrom MR, et al. Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation. AJR Am J Roentgenol. 2003;181:1315–1317.
  • Kam AW, Littrup PJ, Walther MM, et al. Thermal protection during percutaneous thermal ablation of renal cell carcinoma. J Vasc Interv Radiol. 2004;15:753–758.
  • Wang X, Zhao X, Lin T, et al. Thermo-sensitive hydrogel for preventing bowel injury in percutaneous renal radiofrequency ablation. Int Urol Nephrol. 2016;48:1593–1600.
  • Cazzato RL, Garnon J, Shaygi B, et al. How to perform a routine cryoablation under MRI guidance. Top Magn Reson Imaging. 2018;27:33–38.
  • Best SL, Park SK, Yaacoub RF, et al. Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters. J Urol. 2012;187:1183–1189.
  • Gervais DA, Arellano RS, McGovern FJ, et al. Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol. 2005;185:72–80.
  • Tanagho YS, Roytman TM, Bhayani SB, et al. Laparoscopic cryoablation of renal masses: single-center long-term experience. Urology. 2012;80:307–314.
  • Pierorazio PM, Johnson MH, Patel HD, et al. Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-analysis. J Urol. 2016;
  • Sidana A, Aggarwal P, Feng Z, et al. Complications of renal cryoablation: a single center experience. J Urol. 2010;184:42–47.
  • Thompson RH, Atwell T, Schmit G, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 2015;67:252–259.
  • Whitson JM, Harris CR, Meng MV. Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal masses. BJU Int. 2012;110:1438–1443.
  • Guillotreau J, Haber GP, Autorino R, et al. Robotic partial nephrectomy versus laparoscopic cryoablation for the small renal mass. Eur Urol. 2012;61:899–904.
  • Klatte T, Mauermann J, Heinz-Peer G, et al. Perioperative, oncologic, and functional outcomes of laparoscopic renal cryoablation and open partial nephrectomy: a matched pair analysis. J Endourol. 2011;25:991–997.